Summary
This article reviews evidence from the past 20 years on the benefits and risks of antiplatelet therapy for primary and secondary prevention of vascular events.
- Thrombotic Disorders
- © 2012 MD Conference Express®
This article reviews evidence from the past 20 years on the benefits and risks of antiplatelet therapy for primary and secondary prevention of vascular events.